Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 6Gastrointestinal 4Thoracic 2Other hematologic neoplasm 2NET 2Lymphoid 2Genitourinary 2Endocrine 2Breast 2Sarcoma 1Other solid neoplasm 1Head & Neck 1Gynecologic 1Dermatologic 1CNS 1

Conditions

Ovarian Neoplasms 1Frailty 1Endometrial Neoplasms 1Cognitive Dysfunction 1

Interventions

Paclitaxel 140pembrolizumab 119Carboplatin 104Bevacizumab 90Cisplatin 67Specimen Handling 62Magnetic Resonance Spectroscopy 51olaparib 50Gemcitabine 39Nivolumab 36Biopsy 36liposomal doxorubicin 32Taxes 31Cyclophosphamide 31Blood Specimen Collection 29niraparib 27lenvatinib 26Letrozole 26Doxorubicin 26Topotecan 25Drug Therapy 25Immunoglobulin G 22fludarabine 21atezolizumab 21Radiotherapy 21Brachytherapy 21Disulfides 20durvalumab 19Surveys and Questionnaires 19dostarlimab 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Data Collection × Gynecologic × 1 year × Clear all
NCT07220512 2025-10-24

The Better, Harder, Faster, Stronger Study

Wake Forest University Health Sciences

Recruiting
35 enrolled
Gynecologic

Frailty, Ovarian Neoplasms, Endometrial Neoplasms, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡